Related Experiment Videos
Hospital-based strategies for combating resistance
1Department of Medicine, University of Vermont College of Medicine, Burlington, USA.
Summary
Third-generation cephalosporins drive bacterial resistance, unlike some other beta-lactams. Fourth-generation cephalosporins like cefepime offer a solution to combat multidrug-resistant organisms in hospitals.
Area of Science:
- Infectious Diseases
- Microbiology
- Pharmacology
Background:
- Indiscriminate use of beta-lactam antibiotics has led to widespread bacterial resistance.
- Third-generation cephalosporins are linked to the rise of extended-spectrum beta-lactamase (ESBL)-producing and AmpC beta-lactamase-producing Enterobacteriaceae, and vancomycin-resistant enterococci.
- Certain beta-lactams, including cefepime, piperacillin-tazobactam, and ampicillin-sulbactam, exert weaker selective pressures.
Purpose of the Study:
- To evaluate the selective pressures exerted by different classes of beta-lactam antibiotics.
- To identify effective strategies for controlling multidrug-resistant bacteria in institutional settings.
- To assess the role of fourth-generation cephalosporins as alternatives to third-generation agents.
Main Methods:
- Review of institutional strategies for controlling multidrug-resistant bacteria.
- Analysis of antimicrobial stewardship programs, including prospective audit and feedback.
- Evaluation of formulary interventions, therapeutic substitutions, and formulary restrictions.
- Assessment of infection control measures and their impact on antimicrobial resistance.
Main Results:
- Third-generation cephalosporins are associated with significant increases in bacterial resistance.
- Beta-lactams such as cefepime, piperacillin-tazobactam, and ampicillin-sulbactam show less pronounced selective pressure.
- Antimicrobial stewardship and infection control programs are crucial for managing resistance.
- Fourth-generation cephalosporins, exemplified by cefepime, are effective substitutes for third-generation cephalosporins.
Conclusions:
- Minimizing the use of antibiotics strongly linked to resistance is essential.
- Fourth-generation cephalosporins like cefepime can be strategically employed to reduce the impact of third-generation cephalosporins.
- Integrated approaches involving stewardship, formulary management, and infection control are vital for combating antimicrobial resistance.